Compare SDGR & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SDGR | BUR |
|---|---|---|
| Founded | 1990 | 2009 |
| Country | United States | Guernsey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2020 | 2017 |
| Metric | SDGR | BUR |
|---|---|---|
| Price | $18.14 | $4.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $21.00 | $13.58 |
| AVG Volume (30 Days) | 974.4K | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | ★ 45.14 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $255,869,000.00 | ★ $413,360,000.00 |
| Revenue This Year | $0.76 | $104.62 |
| Revenue Next Year | $4.60 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $10.95 | $3.59 |
| 52 Week High | $23.02 | $14.14 |
| Indicator | SDGR | BUR |
|---|---|---|
| Relative Strength Index (RSI) | 71.63 | 53.06 |
| Support Level | $17.26 | $4.15 |
| Resistance Level | $18.12 | $4.54 |
| Average True Range (ATR) | 0.65 | 0.19 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 84.88 | 76.47 |
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services. Its business is funding clients engaged in ongoing legal disputes to pay legal fees and monetize the expected future value of disputes, focusing on large, complex matters. The company has two reportable segments: Principal Finance, which earns maximum revenue and allocates capital to legal finance assets from its balance sheet and through interests in private funds managed by the company, and Asset Management and Other Services, which manages legal finance assets for third-party investors and provides other services to the legal industry.